Literature DB >> 25268126

Readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia among young and middle-aged adults: a retrospective observational cohort study.

Isuru Ranasinghe1, Yongfei Wang1, Kumar Dharmarajan2, Angela F Hsieh1, Susannah M Bernheim1, Harlan M Krumholz3.   

Abstract

BACKGROUND: Patients aged ≥ 65 years are vulnerable to readmissions due to a transient period of generalized risk after hospitalization. However, whether young and middle-aged adults share a similar risk pattern is uncertain. We compared the rate, timing, and readmission diagnoses following hospitalization for heart failure (HF), acute myocardial infarction (AMI), and pneumonia among patients aged 18-64 years with patients aged ≥ 65 years. METHODS AND
FINDINGS: We used an all-payer administrative dataset from California consisting of all hospitalizations for HF (n=206,141), AMI (n=107,256), and pneumonia (n=199,620) from 2007-2009. The primary outcomes were unplanned 30-day readmission rate, timing of readmission, and readmission diagnoses. Our findings show that the readmission rate among patients aged 18-64 years exceeded the readmission rate in patients aged ≥ 65 years in the HF cohort (23.4% vs. 22.0%, p<0.001), but was lower in the AMI (11.2% vs. 17.5%, p<0.001) and pneumonia (14.4% vs. 17.3%, p<0.001) cohorts. When adjusted for sex, race, comorbidities, and payer status, the 30-day readmission risk in patients aged 18-64 years was similar to patients ≥ 65 years in the HF (HR 0.99; 95%CI 0.97-1.02) and pneumonia (HR 0.97; 95%CI 0.94-1.01) cohorts and was marginally lower in the AMI cohort (HR 0.92; 95%CI 0.87-0.96). For all cohorts, the timing of readmission was similar; readmission risks were highest between days 2 and 5 and declined thereafter across all age groups. Diagnoses other than the index admission diagnosis accounted for a substantial proportion of readmissions among age groups <65 years; a non-cardiac diagnosis represented 39-44% of readmissions in the HF cohort and 37-45% of readmissions in the AMI cohort, while a non-pulmonary diagnosis represented 61-64% of patients in the pneumonia cohort.
CONCLUSION: When adjusted for differences in patient characteristics, young and middle-aged adults have 30-day readmission rates that are similar to elderly patients for HF, AMI, and pneumonia. A generalized risk after hospitalization is present regardless of age. Please see later in the article for the Editors' Summary.

Entities:  

Mesh:

Year:  2014        PMID: 25268126      PMCID: PMC4181962          DOI: 10.1371/journal.pmed.1001737

Source DB:  PubMed          Journal:  PLoS Med        ISSN: 1549-1277            Impact factor:   11.069


Introduction

Reducing readmissions is a key focus of current health policy initiatives in the United States (US). The scope of the problem among elderly individuals is well established—one in five Medicare beneficiaries are readmitted within 30 days of discharge, with high cost to the health care system [1]. Hospitalizations, however, are not limited to elderly patients; many young and middle-aged adults aged 18–64 years are also hospitalized. For example, among the conditions that form the basis of current Medicare readmission measures [2]–[4], patients younger than 65 years of age account for approximately 30% of heart failure (HF) admissions [5],[6], 40–45% of acute myocardial infarction (AMI) admissions [7], and 33% of pneumonia admissions [8], and they consume 32% to 44% of aggregated costs for these conditions [9]. Furthermore, while elderly patients aged ≥65 years represent 12.9% of the population, young adults represent nearly 60% of the US population [10]. However, compared with elderly patients, our understanding of readmission risks in these younger patients is limited. This information can help in ascertaining whether the phenomenon of vulnerability after hospital discharge is primarily limited to older patients. Elderly patients experience a period after hospitalization when they are more likely to be readmitted for an array of conditions often unrelated to the index admission diagnosis or the severity of index illness, with the risk highest immediately post-discharge [11]. This increased susceptibility has been referred to as post-hospital syndrome [12]. Whether such a period of increased susceptibility also occurs in young patients is uncertain. Older age is associated with comorbidities, frailty, cognitive and functional impairment, polypharmacy, and social isolation, all of which increase the risk of morbidity. If the post-hospital syndrome is limited to elderly patients, who have these distinctive age-related features, we would expect readmission rates to be lower among those of younger age. Furthermore, if an acquired period of generalized risk is absent in young patients, then we would expect a greater percentage of readmissions to be related to the initial admission diagnosis rather than due to acquired conditions. Although publicly available reports indicate a lower 30-day readmission rate of 5–11% across all conditions in young patients [13],[14], these brief reports have examined neither readmission rates across ages for the same conditions nor the diagnoses or timing of readmissions. Thus, it is difficult to conclude whether a post-hospital syndrome extends to patients younger than 65 years of age. Distinguishing the timing and patterns of readmission seen in the young from those who are older may improve transitional care more broadly and facilitate more effective initiatives to reduce readmissions. Recent policy measures [15],[16] have incentivized interventions to reduce readmissions, yet variable conclusions have been drawn about the effectiveness of existing interventions [17]–[19]. This may reflect a lack of in-depth understanding of the underlying determinants of readmission. Many interventions also target elderly patients [18] and rarely address readmissions in younger patients. Understanding the conditions with which young patients present, and the time frame within the 30 days during which these occur, may inform whether specific interventions for younger patients are required. Using an all-payer dataset from California, we compared the rate, timing, and readmission diagnoses following hospitalization for HF, AMI, and pneumonia between young and middle-aged adults aged 18–64 years and those aged ≥65 years. We chose HF, AMI, and pneumonia, because these conditions are frequent causes of readmissions among both young and elderly patients [13],[20]. HF, AMI, and pneumonia readmissions among Medicare patients aged ≥65 are publicly reported in the US as a measure of hospital quality [2]–[4] and have been extensively studied. Given that we understand the rate, timing and readmission diagnoses among elderly patients with HF, AMI, and pneumonia [11], patients with these conditions form an ideal population in which to perform a comparison with younger patients.

Methods

Ethics Statement

Institutional review board approval for this study, including waiver of the requirement for participant informed consent, was obtained from the Yale University Human Investigation Committee.

Study Population

We identified hospitalizations from California included in the all-payer Healthcare Cost and Utilization Project (HCUP) state inpatient dataset and derived three separate cohorts of hospitalizations with a principal discharge diagnosis of HF, AMI, or pneumonia between January 2007 and November 2009. HF, AMI, and pneumonia were defined with International Classification of Diseases, Ninth Revision Clinical Modification (ICD-9-CM) codes identical to those used in the Centers for Medicare & Medicaid Services (CMS) publicly reported readmission measures [2]–[4] (see Table S1). Hospitalizations for patients aged ≥18 years from each cohort were included. In alignment with the CMS measures, we excluded hospitalizations during which a patient died, was transferred to another hospital, or was discharged against medical advice. We excluded hospitalizations for non-California residents since potential readmissions may not be captured in the state inpatient dataset. Hospitalization occurring after 30 days from previous discharge was counted as a new index admission if hospitalizations met the inclusion criteria. All included hospitalizations were stratified into hospitalizations among young patients aged 18–64 years and those occurring in elderly patients aged ≥65 years. We further subdivided the 18–64 years age group into young (aged 18–39 years) and middle-aged adults (age 40–54 years and 55–64 years) to assess readmission patterns with decreasing age. We presented patient data grouped by these age categories for clarity of presentation. However, to further characterize the association between age and the risk of readmission, and to ensure that the age categories we used were appropriate, we evaluated the association between age and the risk of readmission modeling age as a continuous variable.

Classification of Comorbidities and Readmission Diagnoses

Comorbidities at the index hospitalization were categorized using the CMS condition categories (CCs) model [21], which groups presenting diagnoses into clinically coherent conditions. In contrast, readmission diagnoses were classified using a modified version of the CC model that we previously developed [11] because 85% of the 189 CC groups each accounted for less than 1% of all readmissions. Modified CCs were derived by consolidating common readmission diagnoses into a shorter list of 30 categories. Cardiopulmonary diagnoses were described with greater detail given their importance following index hospitalization for HF, AMI, or pneumonia. These 30 modified CCs were designed to be clinically relevant, internally consistent, and capture the most common readmission diagnoses after discharge from HF, AMI, and pneumonia hospitalizations (see Table S2) [11].

Outcomes Assessment

We identified the first unplanned readmissions due to any cause occurring within 30 days of hospitalization. In keeping with CMS criteria for reporting hospital readmission performance [2]–[4], we excluded planned hospitalizations as identified by the CMS planned readmission algorithm [22]. To determine the timing of readmission among readmitted patients, we calculated the percentage of readmissions occurring on each day (0–30) following discharge.

Readmission Diagnoses

We observed the percentage of readmissions occurring due to each of the 30 modified CCs for HF, AMI, and pneumonia during the 30 days postdischarge. To determine the proportion of readmission diagnoses that related to the index hospitalization diagnosis, we also calculated the proportion of 30-day readmissions occurring due to cardiovascular diagnoses after hospitalizations for HF, AMI, and pulmonary diagnoses following hospitalizations for pneumonia by aggregating the modified CCs (modified CCs comprising cardiovascular and pulmonary diagnoses are listed in Table S3 and Table S4).

Statistical Analysis

Data are summarized as frequencies and percentages for categorical variables. Continuous variables are presented as mean ± standard deviation. The χ2 statistic, Student's t-test and F-test in ANOVA model were used to compare characteristics between age groups as appropriate. The Cochran-Armitage test was used to assess trends across age groups. Risk of readmission following discharge was determined using Kaplan-Meier estimates and age groups were compared using the log-rank test. Risk-adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) for readmission among age groups were derived using a Cox proportional hazards model with adjustment for sex, race, payer status, and comorbidities at index hospitalization. To determine if disease severity influences the risk of readmission, we performed a sensitivity analysis by further adjusting for the length of the index hospital stay as a surrogate for disease severity. We censored patients if they died or did not have a readmission within 30 days of discharge. To evaluate the association between age as a continuous variable and the outcome of readmission within 30 days of discharge, we first derived the fracpoly logistic regression models with 30-day readmission as the dependent variable and age as the main covariate (independent variable), as well as with or without other confounding factors in the models. Then we calculated the unadjusted or adjusted readmission rates from the models with or without the confounding factors separately for each age value. Finally we plotted the association between the age and the unadjusted or adjusted readmission rates. For all statistical analysis, significance levels were 2-sided with a P value<0.05. All analyses were conducted using SAS 9.2 (SAS Institute Inc, Cary, NC).

Results

In California, for all conditions, 6,622,302 hospitalizations occurred among adult patients aged ≥18 years during the study period, which included 4,115,502 hospitalizations among patients aged 18–64 years and 2,506,800 hospitalizations among patients aged ≥65 years. Readmission within 30 days occurred following 10.3% (670,676) of hospitalizations with a readmission rate of 8.2% (336,513) among patients aged 18–65 years and 13.3% (334,163) among those aged ≥65 years. Among all hospitalizations, a total of 206,141 hospitalizations for HF, 107,256 hospitalizations for AMI, and 199,620 hospitalizations for pneumonia met our study inclusion criteria. Among these cohorts, 58,119 (28.2%) hospitalizations for HF, 42,546 (39.7%) hospitalizations for AMI, and 67,049 (33.6%) hospitalizations for pneumonia were among patients aged 18–64 years, while the remainder occurred in patients aged ≥65 years.

Patient Characteristics at Index Hospitalization

The characteristics of the cohorts are described in Tables 1–3. The mean age of patients aged 18–64 years was 52.9 years for HF, 53.9 years for AMI, and 49.7 years for pneumonia, while the mean age of patients aged ≥65 years was approximately 80 years in each cohort. Patients aged 18–64 years were also more likely to be of nonwhite race and have private health insurance or Medicaid recorded as the payer. Among these patients, Medicare was recorded as a payer in 26.0% of HF hospitalizations, 12.3% of AMI hospitalizations, and 23.7% of pneumonia hospitalizations. In contrast, most patients aged ≥65 years were white and nearly 90% of patients in each cohort had Medicare health insurance. Comorbidities were generally less frequent among patients aged 18–64 years compared with elderly patients across all three cohorts, although this difference was less evident in the HF cohort. Across cohorts, comorbidities such as major psychiatric disorders and drug- and alcohol-related disorders were more common among patients aged 18–64 years and, as expected, comorbidities such as stroke (0.8–2.2%) and dementia (0.8–3.3%), were infrequently seen.
Table 1

Baseline characteristics of patients with an index hospitalization for heart failure.

CharacteristicAge Group (Years) p-Value
18–3940–5455–64≥65
No. of hospitalizations 4997235002962258119
Age, mean (SD) 33.0 (5.0)48.6 (4.0)59.7 (2.8)80.0 (7.7)<0.001
Male (%) 65.764.158.645.2<0.001
Race (%)
White26.734.842.262.0<0.001
Black26.330.822.08.4
Hispanic28.323.023.816.7
Other18.811.512.013.0
Payer status (%)
Medicare15.621.931.188.6<0.001
Medicaid36.734.328.84.3
Private insurance22.823.728.86.3
Other24.920.211.30.7
Comorbidities at hospitalization (%)
Congestive heart failure49.052.552.449.6<0.001
Acute coronary syndrome4.810.413.211.9<0.001
Chronic atherosclerosis19.442.057.665.0<0.001
Stroke1.42.02.52.6<0.001
Diabetes and complications28.547.961.847.7<0.001
End-stage renal disease or dialysis10.18.18.54.2<0.001
Chronic obstructive pulmonary disease13.931.838.938.0<0.001
Pneumonia24.124.626.429.4<0.001
Asthma17.912.99.05.8<0.001
Dementia and senility0.51.12.816.8<0.001
Hemiplegia, paralysis, and functional disability3.56.18.56.1<0.001
Major psychiatric disorders7.29.88.54.7<0.001
Drug and alcohol abuse47.850.836.011.1<0.001
Table 3

Baseline characteristics of patients with an index hospitalization for pneumonia.

CharacteristicAge Group (Years) p-Value
18–3940–5455–64≥65
No. of hospitalizations 122882699727764132571
Age, mean (SD) 30.3 (6.1)48.2 (4.08)59.6 (2.8)80.0 (7.8)<0.001
Male (%) 49.449.549.346.3<0.001
Race (%)
White40.651.058.265.9<0.001
Black11.214.810.74.8
Hispanic30.221.819.414.9
Other18.012.511.714.4
Payer status (%)
Medicare12.222.530.089.2<0.001
Medicaid31.326.723.24.3
Private insurance38.136.037.65.9
Other18.414.89.20.6
Comorbidities at hospitalization (%)
Congestive heart failure5.310.916.121.4<0.001
Acute coronary syndrome0.52.33.84.4<0.001
Chronic atherosclerosis2.011.022.937.2<0.001
Stroke0.51.21.72.7<0.001
Diabetes and complications14.929.439.734.6<0.001
End-stage renal disease or dialysis2.83.54.32.2<0.001
Chronic obstructive pulmonary disease8.128.642.445.9<0.001
Pneumonia91.492.292.193.4<0.001
Asthma23.117.811.96.9<0.001
Dementia and senility1.92.44.826.0<0.001
Hemiplegia, paralysis, and functional disability8.66.57.36.4<0.001
Major psychiatric disorders8.113.312.86.8<0.001
Drug and alcohol abuse28.840.734.012.6<0.001

30-Day Readmission Rates

Overall, there were 46,093 (22.4%) readmissions in the HF cohort, 16,117 (15.0%) readmissions in the AMI cohort, and 32,546 (16.3%) readmissions in the pneumonia cohort. The crude readmission rate in patients aged 18–64 years for the HF cohort exceeded the readmission rate observed among patients aged ≥65 years (23.4%, 95%CI 23.0%–23.7% versus 22.0%, 95%CI 21.8%–22.2%, p<0.001). In contrast, the crude readmission rate among patients aged 18–64 years was lower compared with patients aged ≥65 years for the AMI (11.2%, 95%CI 10.9%–11.5% versus 17.5%, 95%CI 17.2%–17.8%, p<0.001) and pneumonia (14.4%, 95%CI 14.1%–14.6% versus 17.3%, 95%CI 17.1%–17.5%, p<0.001) cohorts. Overall, approximately 30% of all 30-day readmissions occurred among patients 18–65 years of age (HF 29.5%, AMI 29.6%, pneumonia 29.6%). When examining the trend across age groups (Table 4), the readmission rate in the HF cohort increased with progressively younger age groups. A readmission rate of 23.3% was observed in patients aged 18–39 years compared to a rate of 22.0% in patients aged ≥65 years (p for trend <0.001). In contrast, the 30-day readmission rate declined with progressively younger age groups in the AMI and pneumonia cohorts (both p for trend <0.001). A readmission rate of 9.3% (AMI) and 10.5% (pneumonia) was observed among patients aged 18–39 years in these cohorts.
Table 4

Hospitalization and readmissions among age groups for HF, AMI, and pneumonia.

CategoryAge Group (Years)Trend p-Valuea
18–3940–5455–64≥65
Heart failure
Hospitalizations (n)49972350029622148022
Readmissions (n)11655506691132511
Readmission rate (%, [95%CI])23.3% [22.1–24.5]23.4% [22.9–24.0]23.3% [22.8–23.8]22.0% [21.8–22.2]<0.001
Myocardial infarction
Hospitalizations (n)1979178952267264710
Readmissions (n)1841880271211341
Readmission rate (%, [95%CI])9.3% [8.0–10.6]10.5% [10.1–11.0]12.0% [11.5–12.4]17.5% [17.2–17.8]<0.001
Pneumonia
Hospitalizations (n)122882699727764132571
Readmissions (n)12953854448222915
Readmission rate (%, [95% CI])10.5% [10.0–11.1]14.3% [13.9–14.7]16.1% [15.7–16.6]17.3% [17.1–17.5]<0.001

p-Value for trend (increase or decrease) across consecutive age groups (18–39, 40–54, 55–64, ≥65 years).

p-Value for trend (increase or decrease) across consecutive age groups (18–39, 40–54, 55–64, ≥65 years).

Association of Age with Readmission Rates following Adjustment for Patient Characteristics

After adjustment for sex, race, payer status, and comorbidities, the adjusted risk of readmission in patients aged 18–64 years was similar to patients ≥65 years in the HF (HR 0.99; 95%CI 0.97–1.02) and pneumonia (HR 0.97; 95%CI 0.94–1.01) cohorts and marginally lower in the AMI cohort (HR 0.92; 95%CI 0.87–0.96). Figure 1 shows the adjusted risk of readmission among subgroups of younger patients compared with patients aged ≥65 years. In the HF cohort, the adjusted risk of readmission was similar among all subgroups of age except in those aged 18–39 years, who had a higher adjusted risk compared with patients aged ≥65 years (HR 1.12; 95%CI 1.05–1.20). In the AMI cohort, the adjusted risk of readmission declined with progressively younger age groups, with an adjusted HR of 0.81 (95%CI 0.70–0.94) in the youngest (18–39 year) age group. In the pneumonia cohort, the adjusted risk of readmission among subgroups of patients aged 18–64 years was similar to elderly patients except in the youngest (18–39 year) age group (HR 0.87; 95%CI 0.81–0.92). Further adjustment for the length of the index hospital stay (as a surrogate for disease severity) made no difference to the risk of readmission (see Table S5).
Figure 1

The adjusted risk of readmission by age group for HF, AMI, and pneumonia cohorts, respectively.

The referent group is patients age ≥65 years within each cohort.

The adjusted risk of readmission by age group for HF, AMI, and pneumonia cohorts, respectively.

The referent group is patients age ≥65 years within each cohort. Figure 2 shows the association between age and the risk of readmission with age modeled as a continuous variable. The crude readmission rate varied considerably with age and disease condition. The adjusted rate of readmission for HF declined with increasing age, reaching a nadir at approximately 75 years of age before gradually increasing with increasing age thereafter. The adjusted rate of readmission for AMI shows a relatively stable rate among young patients but gradually rises after the age of 60–65 years. Similarly, for pneumonia, the adjusted rate of readmission was stable with increasing age until the age of 70–75 years after which the rate of readmission increases. Overall, the adjusted rates of readmission for the three cohorts were similar across a broad age range with the exception of upper extremes of age (>85 years) where the readmission rate rises rapidly with further acceleration above the age of 95 years.
Figure 2

Crude and adjusted rate of readmission with increasing age for HF, AMI, and pneumonia.

Age is modeled as a continuous variable using a flexible function. The dotted lines indicate the confidence intervals (5th and 95th percentile) for each cohort.

Crude and adjusted rate of readmission with increasing age for HF, AMI, and pneumonia.

Age is modeled as a continuous variable using a flexible function. The dotted lines indicate the confidence intervals (5th and 95th percentile) for each cohort.

Timing and Risk of Readmission

Figure 3 shows the proportion of patients readmitted within consecutive periods 0–3, 4–7, 8–14 and 15–30 days following discharge for each cohort. For all cohorts, most readmissions among patients aged 18–64 years occurred within 0–3 days (HF 13%, AMI 19%, pneumonia 15%) and 4–7 days (HF 19%, AMI 21%, pneumonia 19%). The proportion of young patients readmitted within each time period was similar to patients aged ≥65 years and was broadly similar across all subgroups of patients aged 18–64 years.
Figure 3

Percentage of readmissions by consecutive time periods following hospital discharge across age groups for HF, AMI, and pneumonia.

Figure 4 shows the percentage of 30-day readmissions occurring on each day postdischarge by age group for HF, AMI, and pneumonia cohorts. For all three cohorts, the risks of readmission were highest between days 2 and 5 after discharge. A gradual decline in the population risk was seen thereafter. There was no difference in risk of readmission by day postdischarge with age for any cohort as indicated by a significant overlap of curves for each age group.
Figure 4

Readmission incidence rate by each day post-discharge by age group for HF, AMI, and pneumonia cohorts.

The most frequent readmission diagnoses based on modified CCs by age group are shown in Table 5 (complete list by age group is given in Table 6 for HF, Table 7 for AMI, and Table 8 for pneumonia). In the HF cohort, HF was the most common principal readmission diagnosis in all age groups. With progressively younger age groups, HF was more frequently observed as the principal readmission diagnosis (increasing from 35.6% in those aged ≥65 years to 49.6% among those aged 18–39 years, p for trend <0.001). In the pneumonia cohort, pneumonia was the most common principal readmission diagnosis. With progressively younger age groups, pneumonia as a principal readmission diagnosis remained unchanged (22.2% in those aged ≥65 years to 23.2% in those aged 18–39 years, p for trend = 0.113). In the AMI cohort, HF was the principal readmission diagnosis among those aged ≥65 years. However, with progressively younger age groups, chest pain was observed to be the most frequent principal readmission diagnosis. Irrespective of age or cohort, a range of heterogeneous yet individually infrequent readmission diagnoses were present. For example, among 18–64-year-old patients in the HF cohort, 27 of the 30 modified CCs had a frequency <5% and a further 508 distinct primary ICD9-CM diagnoses (all with an individual frequency <1%) contributed to the “other” modified CC category.
Table 5

Principal diagnosis at readmission by age group for HF, AMI, and pneumonia.

CharacteristicAge Group (Years)Trend p-Valuea
18–3940–5455–64≥65
n%n%n%n%
Heart failure
Heart failure57849.6248945.2291842.21156935.6<0.001
Renal disorders including renal failure1038.84037.35477.926768.20.131
Pneumonia including aspiration pneumonia363.11963.62233.217505.4<0.001
Septicemia/shock171.51202.22093.016195.0<0.001
Cardio-respiratory failure322.71833.32553.712193.70.035
Readmission for a cardiac diagnosisb 71661.5326259.2389256.31646750.6<0.001
Myocardial infarction
Heart failure137.121511.438614.2215719.0<0.001
Acute myocardial infarction1910.31869.92539.311249.90.790
Chest pain3820.732117.12699.94313.8<0.001
Complications of care116.01618.62198.15384.7<0.001
Chronic angina and coronary artery disease147.61749.31886.95474.8<0.001
Readmission for a cardiac diagnosisb 11562.5117562.5148154.6599252.2<0.001
Pneumonia
Pneumonia including aspiration pneumonia30123.281221.184918.9507622.20.113
Septicemia/shock735.62366.13848.622399.8<0.001
Heart failure594.62376.12776.218498.1<0.001
Chronic obstructive pulmonary disease594.63278.54379.815686.80.029
Cardio-respiratory failure423.21544.02706.011895.2<0.001
Readmission for a respiratory diagnosisb 46135.6147938.4175339.1871038.00.688

p-Value for trend (increase or decrease) across consecutive age groups (18–39, 40–54, 55–64, ≥65 years).

Readmission diagnosis grouped into cardiovascular and respiratory diagnoses based on criteria indicated in Tables S3 and S4.

Table 6

Principal readmission diagnosis within 30 days by modified condition categories among patients with an index hospitalization for heart failure.

DescriptionAge Group (Years)
18–3940–5455–64≥65
n%n%n%n%
Heart failure57849.6248945.2291842.21156936.0
Acute myocardial infarction50.4801.51341.97832.4
Unstable angina and other acute ischemic heart disease20.2190.4150.2390.1
Chronic angina and coronary artery disease30.3520.91051.53231.0
Valvular/rheumatic heart disease30.3260.5420.63851.2
Other cardiac disease including congenital heart and hypertensive disease242.1601.1620.92160.7
Arrhythmias and conduction disorders161.41212.21952.810013.1
Pleural effusion/pneumothorax50.4190.4370.52220.7
Chest pain504.32204.01562.33831.2
Syncope40.3120.2300.42100.7
Acute stroke/transient ischemic attack110.9801.51011.57682.4
Pulmonary embolism/deep venous thrombosis151.3380.7410.61590.5
Other peripheral vascular disease50.4651.2931.46311.9
Cardio-respiratory failure322.81833.32553.712193.8
Chronic obstructive pulmonary disease110.91983.62363.49412.9
Pneumonia including aspiration pneumonia363.11963.62233.217505.4
Septicemia/shock171.51202.22093.016195.0
Urinary tract infection30.3180.3440.65871.8
Cellulitis60.5691.3751.12550.8
Clostridium difficile-associated infection10.170.1240.42920.9
Renal disorders including renal failure1038.84037.35477.926768.2
Anemia40.3150.3340.52740.8
Gastrointestinal hemorrhage40.3370.7811.26321.9
Diabetes and its complications272.31192.21692.55591.7
Fibrosis of lung and other chronic lung disorders20.2100.2140.2910.3
Hip fracture00.060.1220.32870.9
Complications of care393.42033.72583.78342.6
Other lung disorders including acute, congenital, and unspecified lung abnormalities40.3190.4210.3890.3
Primary cancer of the trachea, bronchus, lung, and pleura00.030.130.0580.2
Othera 15513.361911.276711.1365911.3

Among patients aged 18–64 years, the “other” modified CC consisted of 508 distinct ICD-9-CM diagnoses. In comparison, among patients aged ≥65, the “other” modified CC consisted of 794 distinct ICD-9-CM diagnoses.

Table 7

Principal readmission diagnosis within 30 days by modified condition categories among patients with an index hospitalization for myocardial infarction.

DescriptionAge Group (Years)
18–3940–5455–64≥65
n%n%n%n%
Heart failure137.121511.438614.2215719.0
Acute myocardial infarction1910.31869.92539.311249.9
Unstable angina and other acute ischemic heart disease147.6844.5762.82342.1
Chronic angina and coronary artery disease147.61749.31886.95474.8
Valvular/rheumatic heart disease00.020.160.2680.6
Other cardiac disease including congenital heart and hypertensive disease42.2442.3381.4890.8
Arrhythmias and conduction disorders52.7392.1762.84233.7
Pleural effusion/pneumothorax10.5110.6341.3540.5
Chest pain3820.732117.12699.94313.8
Syncope10.5181.0261.01141.0
Acute stroke/transient ischemic attack31.6341.8642.43363.0
Pulmonary embolism/deep venous thrombosis21.1301.6291.11461.3
Other peripheral vascular disease21.1281.5702.62532.2
Cardio-respiratory failure31.6241.3592.23593.2
Chronic obstructive pulmonary disease21.1251.3421.62171.9
Pneumonia including aspiration pneumonia31.6402.1823.05434.8
Septicemia/shock42.2402.1863.25805.1
Urinary tract infection31.6130.7271.02212.0
Cellulitis21.1100.5210.8530.5
Clostridium difficile-associated infection00.030.2110.41271.1
Renal disorders including renal failure42.2532.81174.36065.3
Anemia00.060.3210.8990.9
Gastrointestinal hemorrhage10.5211.1532.03332.9
Diabetes and its complications42.2341.8461.71671.5
Fibrosis of lung and other chronic lung disorders00.030.250.2100.1
Hip fracture00.000.040.2710.6
Complications of care116.01618.62198.15384.7
Other lung disorders including acute, congenital, and unspecified lung abnormalities21.160.3140.5240.2
Primary cancer of the trachea, bronchus, lung, and pleura00.030.280.3220.2
Othera 2915.825213.438214.1139512.3

Among patients aged 18–64 years, the “other” modified CC consisted of 298 distinct ICD-9-CM diagnoses. In comparison, among patients aged ≥65, the “other” modified CC consisted of 480 distinct ICD-9-CM diagnoses.

Table 8

Principal readmission diagnosis within 30-days by modified condition categories among patients with an index hospitalization for pneumonia.

DescriptionAge Group (Years)
18–3940–5455–64≥65
n%n%n%n%
Heart failure594.62376.22776.218498.1
Acute myocardial infarction10.1240.6541.22991.3
Unstable angina and other acute ischemic heart disease10.150.160.1160.1
Chronic angina and coronary artery disease10.190.2250.6680.3
Valvular/rheumatic heart disease00.070.270.2670.3
Other cardiac disease including congenital heart and hypertensive disease120.9300.8240.51160.5
Arrhythmias and conduction disorders70.5260.7531.24451.9
Pleural effusion/pneumothorax262.0731.9651.52721.2
Chest pain131.0832.2671.52080.9
Syncope10.1110.3150.31180.5
Acute stroke/transient ischemic attack60.5240.6431.04221.8
Pulmonary embolism/deep venous thrombosis322.5651.7531.22851.2
Other peripheral vascular disease40.3300.8631.43021.3
Cardio-respiratory failure423.21544.02706.011895.2
Chronic obstructive pulmonary disease594.63278.54379.815686.8
Pneumonia including aspiration pneumonia30123.281221.184918.9507622.2
Septicemia/shock735.62366.13848.622399.8
Urinary tract infection181.4371.0501.15082.2
Cellulitis100.8511.3491.11580.7
Clostridium difficile-associated infection110.9391.0541.26192.7
Renal disorders including renal failure544.21413.72174.811895.2
Anemia50.4180.5420.92321.0
Gastrointestinal hemorrhage161.2310.8591.34341.9
Diabetes and its complications282.2481.3701.62781.2
Fibrosis of lung and other chronic lung disorders161.2481.3481.12511.1
Hip fracture20.2100.3190.42551.1
Complications of care513.91483.81383.14341.9
Other lung disorders including acute, congenital, and unspecified lung abnormalities171.3320.8290.71160.5
Primary cancer of the trachea, bronchus, lung, and pleura00.0330.9551.22381.0
Othera 42933.1106527.696021.4366416.0

Among patients aged 18–64 years, the “other” modified CC consisted of 679 distinct ICD-9-CM diagnoses. In comparison, among patients aged ≥65, the “other” modified CC consisted of 838 distinct ICD-9-CM diagnoses.

p-Value for trend (increase or decrease) across consecutive age groups (18–39, 40–54, 55–64, ≥65 years). Readmission diagnosis grouped into cardiovascular and respiratory diagnoses based on criteria indicated in Tables S3 and S4. Among patients aged 18–64 years, the “other” modified CC consisted of 508 distinct ICD-9-CM diagnoses. In comparison, among patients aged ≥65, the “other” modified CC consisted of 794 distinct ICD-9-CM diagnoses. Among patients aged 18–64 years, the “other” modified CC consisted of 298 distinct ICD-9-CM diagnoses. In comparison, among patients aged ≥65, the “other” modified CC consisted of 480 distinct ICD-9-CM diagnoses. Among patients aged 18–64 years, the “other” modified CC consisted of 679 distinct ICD-9-CM diagnoses. In comparison, among patients aged ≥65, the “other” modified CC consisted of 838 distinct ICD-9-CM diagnoses. When readmission principal diagnoses were more broadly grouped, a cardiovascular diagnosis accounted for a higher proportion of readmissions among patients aged 18–64 years compared with those aged ≥65 years in the HF and AMI cohorts. With progressively younger age groups, the proportion of cardiovascular readmissions increased for both HF and AMI cohorts (both p for trend <0.001), suggesting less diversity in readmission diagnoses in younger patients. In contrast, in the pneumonia cohort, a respiratory diagnosis accounted for 38.3% of all readmissions among patients aged 18–64 years. This finding is similar to those aged ≥65 (38.0%) and unchanged with progressively younger age groups (p for trend = 0.7). Nevertheless, among younger patient age groups, a noncardiac diagnosis consistently represented 40–44% of readmissions in the HF cohort and 35–45% of readmissions in the AMI cohort. Similarly, a nonpulmonary diagnosis was present in 61–64% of patients in the pneumonia cohort. This suggests a diverse array of readmissions unrelated to the index hospitalization among young patients aged 18–64 years.

Discussion

We observed that patients aged 18–64 years had a high rate of 30-day readmission following hospitalization. In these patients, 11.2% were readmitted after an index hospitalization for AMI, 14.4% were readmitted after an index hospitalization for pneumonia, and 23.4% were readmitted after an index hospitalization for HF. Indeed, in the HF cohort, the 30-day readmission rate in patients aged 18–64 years consistently exceeded the readmission rate seen in elderly patients. Following adjustment for patient characteristics other than age, young and middle-aged adults had 30-day readmission rates that were similar to elderly patients. The timing of readmission in patients aged 18–64 years was similar to patients aged ≥65 years, and, like elderly patients [11], the risk of readmission among these patients was highest immediately after discharge and progressively declined thereafter. While the readmission diagnoses were less diverse, many of the conditions that younger patients presented with were also unrelated to the index hospitalization akin to the well-documented readmission patterns seen in elderly patients [1],[11],[23]–[25]. For HF, AMI, and pneumonia, our observations suggest that patients aged 18–64 years, like those aged ≥65 years, may also experience a post-hospital syndrome [11],[12], albeit to a lesser degree than seen in elderly patients [11],[12]. Furthermore, these observations suggest that the increased risk of readmission for a wide range of conditions is not an issue solely limited to elderly patients. Rather, our findings suggest that the risk of readmission for a diversity of causes is a pervasive issue experienced by adult patients of all ages following hospitalization. Two studies have reported data relevant to readmission among young patients and our findings should be evaluated in the context of these studies. Sommers et al [14], using data from 5,805 patients, evaluated physician visits following hospital discharge, and reported an all-cause readmission rate of 5% among patients aged 21–44 years and 9.5% among those aged 45–64 years. A HCUP statistical brief also reported a 30-day readmission rate for nonobstetrical causes following any hospitalization of up to 10.7% in patients aged 21–64 years [13]. In this study, 25% of all readmissions among young patients occurred following an index hospitalization for circulatory or respiratory disease, with a 30-day readmission rate among these conditions of 11% and 10%, respectively [13]. Our study extends the literature by undertaking an in-depth consideration of readmission timing and diagnosis among younger patients for HR, AMI, and pneumonia, conditions that are among the most common circulatory and pulmonary conditions. To our knowledge this has not been previously examined in patients aged younger than 65 years. In elderly patients, a transient period of acquired vulnerability, termed post-hospital syndrome, is present following hospitalization [11],[12]. Among elderly patients aged ≥65 years, the readmission rates for HF, AMI, and pneumonia are consistently high (18.3%–24.8%) [11]. In contrast, among younger patients aged 18–64 years, the observed readmission rates were more variable across cohorts and age groups. This variation between cohorts was more prominent in the youngest age group (18–39 years), where the readmission rate varied from 9.3% (AMI) to 23.3% (HF). The readmission diagnosis in patients 18–64 years of age was more likely to be related to the index admission diagnosis compared with elderly patients. While this is less consistent with an acquired vulnerability post-hospitalization, a noncardiac diagnosis nevertheless represented a large portion of readmissions in the HF (42.1%) and AMI (42%) cohorts, with a nonpulmonary diagnosis present in 61–64% of patients in the pneumonia cohort in patients aged 18–64 years. The underlying etiological and presentation characteristics for HF, AMI, and pneumonia do differ across age groups. For example, cardiomyopathies, myocarditis, and congenital abnormalities are associated with HF in young patients, whereas coronary disease and hypertension commonly cause HF in elderly patients [26]. These differences may explain the variation in readmission patterns across cohorts and within age groups. Such etiological differences in the cause of HF may explain why patients with HF aged 18–39 years had a higher rate of readmission compared with older patients with HF even when adjusted for other covariates. In contrast to these differences, striking similarities in timing and risk of readmission post-discharge were observed between young and elderly patients; irrespective of the index diagnosis or age, a quantitatively similar heightened risk of readmission appears to exist for these populations immediately after hospital discharge and gradually declines. Furthermore, the proportion of patients that re-present within each consecutive time period post-discharge was remarkably consistent across age groups. Both these findings are highly suggestive of an acquired risk post-hospitalization. Our study raises questions regarding the possible contributing factors to such an acquired risk. Elderly patients are well known to experience age-related factors such as cognitive and functional impairment [27], social isolation [28], and polypharmacy [29],[30]. Hospitalization in this context has been associated with undesirable consequences including functional decline [31], heightened risk of delirium [32], and greater adverse effects from therapeutic agents [33]. In contrast, physiological and psychological effects of hospitalization on young adults are largely unknown. More importantly, the adjusted risk of readmission among patients aged 18–39 years was only marginally lower when compared with the elderly patients and indeed higher in the HF cohort. The high risk of readmission even among the very young (18–34 year) age group, who are least likely to experience age-related factors, suggests the presence of alternate determinants of readmission among these age groups. Comorbidities and sociodemographic characteristics may contribute to the high risk of readmission among young patients. Comorbidities were common among young patients. While many young adults in the community are healthy, young patients who are ultimately hospitalized with HR, AMI, and pneumonia may carry a sizable comorbidity burden. Specifically, comorbidities such as drug and alcohol abuse and psychiatric conditions were more common among younger age groups and particularly among those with HF. Substance abuse and psychiatric disorders increase the risk of readmission and other adverse outcomes such as mortality following hospitalization for HF, AMI, and pneumonia [33]–[36]; these disorders may contribute to the high rate of readmission among younger patients. However, it is important to note that drug and alcohol abuse and psychiatric illness were not a common principal readmission diagnosis. Therefore, while these factors may act as contributing factors, these conditions per se do not appear to be responsible for readmissions. A sizable proportion of young patients in our cohort had Medicare as the payer for hospitalization charges. Patients aged <65 years are eligible for Medicare in the event of a disability or a chronic condition. These patients may have a high burden of disease compared with the general population and may explain the higher rate of readmission observed. Furthermore, hospitalized younger patients were more likely to be African American, Hispanic, or other non-white races; these patients have higher rates of readmission compared with white patients [36]. We observed that adjustment for the difference in comorbidities, payer status, and race resulted in a substantial change in the crude and adjusted rates observed in the HF cohort among younger patients (Figure 2), which may further suggest that these factors contribute importantly to the risk of readmission among younger patients. Moreover, lower socioeconomic status and poor access to health care are also known to contribute to readmissions [36]. We did not measure these factors although they may have contributed to the high rate of readmission among younger patients, in addition to the potential etiological differences. Further studies are required to evaluate the contribution of comorbidities and sociodemographic characteristics to readmission among younger patients, as they may provide targets for intervention to reduce readmissions among these patients. Our findings have implications for initiatives aimed at reducing hospital readmissions and health care costs. First, recent US policy measures [15],[16] to reduce readmissions, including public reporting of HF, AMI, and pneumonia, primarily target elderly Medicare patients. Given that young patients form a sizable volume of patients with high health care expenditure [9], and contribute to 30% of all readmissions, extending these initiatives to encompass young patients may lead to improved quality of care and reduced health care expenditure. Second, recent policy changes such as the Hospital Readmissions Reduction Program have incentivized interventions to reduce readmissions by enforcing financial penalties on hospitals with high readmission rates [15]. Many of these targeted interventions are aimed at elderly patients [18],[19]. Our finding of a generalized risk of readmission, and broad yet predictable readmission diagnoses and timing, strongly suggests the need for development of more broad-based multidisciplinary strategies to mitigate this risk. Finally, further research should focus on better understanding the drivers of readmission in young patients. Understanding the psychological and physiological effects of hospitalization, and the contributing effects of comorbidities such as substance abuse, may guide the development of more effective interventions relevant to young patients. Our study has important issues to consider. First, our data are derived from a single state (California). However, this is the most populous US state, with 37.2 million residents or 12.1% of the overall US population [10]. Furthermore, the overall rates of readmission seen among the elderly population in our study are consistent with rates of readmission reported in prior national studies [1],[11], indicating that the California population is likely to be representative of a national sample. Second, we analyzed patients with an index diagnosis of HF, AMI, and pneumonia, the measures that are publicly reported by CMS. These conditions may not reflect the patterns for other diagnoses. Third, out-of-hospital deaths may have occurred during the 30 days following the index hospitalization. Out-of-hospital deaths within 30 days may be disproportionately higher among older patients and may result in a lower observed rate of readmission among these patients. HCUP data do not capture out-of-hospital deaths post-index hospitalization, and we cannot assess the impact of the competing risk of mortality. However, the absolute number of readmissions exceeds the number of deaths occurring within the 30 days and we anticipate the effects of any potential bias to be small [2]–[4],[34],[35]. The declining risk of readmission observed with time following hospitalization reflects the decline in the risk for the population as a whole. However, the risk of readmission for an individual patient may vary based on specific patient characteristics and circumstances. Lastly, our analysis was based on administrative data rather than clinical data. However, HCUP data are widely used and have been shown to be accurate when validated against chart review data [36],[37].

Conclusion

In our study, nearly 30% of all readmissions for heart failure, acute myocardial infarction, and pneumonia occurred in young and middle-aged adults. When adjusted for differences in patient characteristics, young and middle-aged adults had 30-day readmission rates that were similar to elderly patients. While readmission is often perceived as a problem among elderly patients, our data suggest that readmission should be considered as a broader issue that extends to all hospitalized patients. The post-hospital syndrome, a period of generalized risk after hospitalization, appears to be present regardless of age. International Classification of Diseases, Ninth Revision, Clinical Modification Codes Used to Define Heart Failure, Acute Myocardial Infarction, and Pneumonia Cohorts. (DOCX) Click here for additional data file. Modified Condition Category Constituents. (DOCX) Click here for additional data file. Modified Condition Category codes for cardiovascular diagnoses. (DOCX) Click here for additional data file. Modified Condition Category codes for pulmonary diagnoses. (DOCX) Click here for additional data file. Adjusted 30-day risk of readmission with the addition of length of index hospital stay as a measure of disease severity. (DOCX) Click here for additional data file.
Table 2

Baseline characteristics of patients with an index hospitalization for acute myocardial infarction.

CharacteristicAge Group (Years) p-Value
18–3940–5455–64≥65
No. of hospitalizations 1979178952267264710
Age, mean (SD) 34.4 (4.5)48.8 (3.9)59.6 (2.8)78.3 (7.9)<0.001
Male (%) 76.676.071.452.2<0.001
Race (%)
White44.454.058.766.6<0.001
Black10.99.07.35.2
Hispanic25.520.619.114.5
Other19.216.414.913.8
Payer status (%)
Medicare6.78.715.786.8<0.001
Medicaid17.315.013.23.2
Private insurance53.355.855.38.9
Other22.720.515.91.0
Comorbidities at hospitalization (%)
Congestive heart failure5.86.08.916.6<0.001
Acute coronary syndrome5.56.88.210.8<0.001
Chronic atherosclerosis67.781.384.279.5<0.001
Stroke0.50.70.92.0<0.001
Diabetes and complications23.931.439.740.3<0.001
End-stage renal disease or dialysis2.72.02.92.1<0.001
Chronic obstructive pulmonary disease2.99.015.422.5<0.001
Pneumonia5.15.17.815.7<0.001
Asthma7.25.04.63.9<0.001
Dementia and senility0.20.41.214.9<0.001
Hemiplegia, paralysis, and functional disability1.62.13.04.1<0.001
Major psychiatric disorders3.03.83.73.40.020
Drug and alcohol abuse4.34.23.72.1<0.001
  25 in total

Review 1.  A systematic review of discharge arrangements for older people.

Authors:  S G Parker; S M Peet; A McPherson; A M Cannaby; K Abrams; R Baker; A Wilson; J Lindesay; G Parker; D R Jones
Journal:  Health Technol Assess       Date:  2002       Impact factor: 4.014

2.  Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.

Authors:  Maria Cristina G Passarelli; Wilson Jacob-Filho; Albert Figueras
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  Comorbidity indices to predict mortality from Medicare data: results from the national registry of atrial fibrillation.

Authors:  Yan Yan; Elena Birman-Deych; Martha J Radford; David S Nilasena; Brian F Gage
Journal:  Med Care       Date:  2005-11       Impact factor: 2.983

4.  The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001.

Authors:  Frederick A Masoudi; Charles A Baillie; Yongfei Wang; W David Bradford; John F Steiner; Edward P Havranek; JoAnne Micale Foody; Harlan M Krumholz
Journal:  Arch Intern Med       Date:  2005-10-10

Review 5.  Polypharmacy in the elderly: a literature review.

Authors:  Maryann M Fulton; Elizabeth Riley Allen
Journal:  J Am Acad Nurse Pract       Date:  2005-04

6.  The relation of social isolation, loneliness, and social support to disease outcomes among the elderly.

Authors:  Joe Tomaka; Sharon Thompson; Rebecca Palacios
Journal:  J Aging Health       Date:  2006-06

7.  Prevalence and severity of cognitive impairment with and without dementia in an elderly population.

Authors:  J E Graham; K Rockwood; B L Beattie; R Eastwood; S Gauthier; H Tuokko; I McDowell
Journal:  Lancet       Date:  1997-06-21       Impact factor: 79.321

8.  Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia.

Authors:  Kumar Dharmarajan; Angela F Hsieh; Zhenqiu Lin; Héctor Bueno; Joseph S Ross; Leora I Horwitz; José Augusto Barreto-Filho; Nancy Kim; Susannah M Bernheim; Lisa G Suter; Elizabeth E Drye; Harlan M Krumholz
Journal:  JAMA       Date:  2013-01-23       Impact factor: 56.272

9.  An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction.

Authors:  Harlan M Krumholz; Yun Wang; Jennifer A Mattera; Yongfei Wang; Lein Fang Han; Melvin J Ingber; Sheila Roman; Sharon-Lise T Normand
Journal:  Circulation       Date:  2006-03-20       Impact factor: 29.690

10.  Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records.

Authors:  Yuka Kiyota; Sebastian Schneeweiss; Robert J Glynn; Carolyn C Cannuscio; Jerry Avorn; Daniel H Solomon
Journal:  Am Heart J       Date:  2004-07       Impact factor: 4.749

View more
  40 in total

1.  Patient Readmission Rates For All Insurance Types After Implementation Of The Hospital Readmissions Reduction Program.

Authors:  Enrico G Ferro; Eric A Secemsky; Rishi K Wadhera; Eunhee Choi; Jordan B Strom; Jason H Wasfy; Yun Wang; Changyu Shen; Robert W Yeh
Journal:  Health Aff (Millwood)       Date:  2019-04       Impact factor: 6.301

2.  Sex Differences in 1-Year All-Cause Rehospitalization in Patients After Acute Myocardial Infarction: A Prospective Observational Study.

Authors:  Rachel P Dreyer; Kumar Dharmarajan; Kevin F Kennedy; Philip G Jones; Viola Vaccarino; Karthik Murugiah; Sudhakar V Nuti; Kim G Smolderen; Donna M Buchanan; John A Spertus; Harlan M Krumholz
Journal:  Circulation       Date:  2017-02-07       Impact factor: 29.690

3.  Etiological Role of Diet in 30-Day Readmissions for Heart Failure: Implications for Reducing Heart Failure-Associated Costs via Culinary Medicine.

Authors:  Alexander C Razavi; Dominique J Monlezun; Alexander Sapin; Leah Sarris; Emily Schlag; Amber Dyer; Timothy Harlan
Journal:  Am J Lifestyle Med       Date:  2019-07-14

4.  Sex Differences in Trajectories of Risk After Rehospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia.

Authors:  Rachel P Dreyer; Kumar Dharmarajan; Angela F Hsieh; John Welsh; Li Qin; Harlan M Krumholz
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-05

5.  Differences in Hospital Readmission Risk across All Payer Groups in South Carolina.

Authors:  Hrishikesh Chakraborty; Robert Neal Axon; Jordan Brittingham; Genevieve Ray Lyons; Laura Cole; Christine B Turley
Journal:  Health Serv Res       Date:  2016-09-28       Impact factor: 3.402

Review 6.  Role of Angiotensin Receptor-Neprilysin Inhibition in Heart Failure.

Authors:  Stuart B Prenner; Sanjiv J Shah; Clyde W Yancy
Journal:  Curr Atheroscler Rep       Date:  2016-08       Impact factor: 5.113

7.  Relationship Between Age and Trajectories of Rehospitalization Risk in Older Adults.

Authors:  Kumar Dharmarajan; Angela Hsieh; Rachel P Dreyer; Jack Welsh; Li Qin; Harlan M Krumholz
Journal:  J Am Geriatr Soc       Date:  2016-11-22       Impact factor: 5.562

Review 8.  Can hospitalization be hazardous to your health? A nosocomial based stress model for hospitalization.

Authors:  Bernard P Chang
Journal:  Gen Hosp Psychiatry       Date:  2019-07-26       Impact factor: 3.238

9.  Seasonality and Readmission after Heart Failure, Myocardial Infarction, and Pneumonia.

Authors:  Neel M Butala; Eric A Secemsky; Jason H Wasfy; Kevin F Kennedy; Robert W Yeh
Journal:  Health Serv Res       Date:  2017-08-31       Impact factor: 3.402

10.  Decade-Long Trends in the Frequency of 90-Day Rehospitalizations After Hospital Discharge for Acute Myocardial Infarction.

Authors:  Han-Yang Chen; Mayra Tisminetzky; Jorge Yarzebski; Joel M Gore; Robert J Goldberg
Journal:  Am J Cardiol       Date:  2015-12-13       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.